On site of action of grayanotoxin in domain 4 segment 6 of rat skeletal muscle sodium channel  by Kimura, Takahiro et al.
On site of action of grayanotoxin in domain 4 segment 6 of rat skeletal
muscle sodium channel
Takahiro Kimuraa, Eiji Kinoshitaa, Kaoru Yamaokaa, Tsunetsugu Yukia,
Masuhide Yakehirob, Issei Seyamaa;*
aDepartment of Physiology, School of Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, Japan
bDivision of Physiology, Department of Clinical Engineering, Hiroshima International University, Faculty of Health Sciences, 555-36 Gakuendai,
Kurose-cho, Kamo-gun, Hiroshima Prefecture 732-0695, Japan
Received 4 November 1999; received in revised form 2 December 1999
Edited by Shozo Yamamoto
Abstract Grayanotoxin I (GTX I) is a diterpenoid extracted
from the family of Ericaceae that binds to Na+ channels and
causes persistent activation. We investigated the interaction of
GTX I with the amino acid residues I1575, F1579 and Y1586 in
transmembrane segment D4S6 of W1. In F1579A, GTX shifted
the threshold potential about 50 mV in the hyperpolarizing
direction and modified Na+ channels twice as efficiently as that
in wild-type. In contrast, these GTX-effects were eliminated
completely in the I1575A mutant and were reduced substantially
in mutant Y1586A. Lysine substitution for F1579 significantly
reduced and for Y1586 completely eradicated the GTX-effect.
Our data suggest that the GTX receptor site shares overlapping
but non-identical molecular determinants with BTX in D4S6 and
has common molecular determinants in D1S6.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Modi¢cation of a certain function of Na channels by bio-
logical toxins is so speci¢c that it is utilized as a pharmaco-
logical probe for clarifying the functional structure of Na
channels. Among biological toxins, the so-called lipid soluble
toxins, such as GTX, BTX, veratiridine and aconitine, are
endowed with some characteristics in common: (1) they
bind to the Na channel in its open state; (2) the modi¢ed
Na channels lose the inactivation process; and (3) the acti-
vation voltage of the modi¢ed Na channels shifts to the
direction of hyperpolarization [1]. The e¡ects of these toxins
suggest that their binding site may contain amino acids that
are crucial for both activation and inactivation gating mech-
anisms. Recent site-directed mutagenesis studies of W1 showed
that replacement of I433, N434 or L437 within D1S6 with the
positively charged residue, lysine, abolishes the BTX- and
GTX-e¡ects, suggesting that these amino acid residues in
D1S6 are critical components of both the GTX and BTX
receptor site [2,3]. Furthermore, aware of the allostric inter-
action in RBIIA between local anesthetics and BTX, Linford
et al. [4] replaced the amino acid residues of the binding sites
for local anesthetics in D4S6 one by one with alanine, and
showed that I1760 and F1764 are other possible binding sites
for BTX. Wang and Wang [2] provided other supportive evi-
dence for the BTX binding site in D4S6: replacement of
F1579 in W1 (corresponding to F1764 in RBIIA) with lysine
also abolishes the BTX-e¡ect, but the same replacement of
Y1586 (homologous to Y1771 in RBIIA) does not.
In this study, three amino acids in I1575, F1579 and Y1586
in D4S6 in W1 were converted to either alanine or lysine, and
the resulting mutants were tested for the GTX-e¡ect by tran-
sient expression in HEK 293. GTX failed to modify the
I1575A and Y1586K mutants and was much less e¡ective in
the F1579K and Y1586A mutants than in WT, but it was
twice as e¡ective in F1579A, indicating that the GTX receptor
sites do not coincide with the BTX sites but partially overlap
them. The signi¢cance of the di¡erence in the sensitivities of
these mutants between GTX and BTX will be discussed.
2. Materials and methods
2.1. Construction of site-speci¢c mutants
The K-subunit of rat skeletal muscle Na channel, W1 cDNA [5],
was cloned into the EcoRI site of a mammalian expression vector
pcDNA3.1(-) (Invitrogen) and pcDNAW1 was constructed. To pro-
duce site-speci¢c mutants of transmembrane segment D4S6 in W1,
¢rstly, a unique endonuclease restriction site, the HpaI site, was cre-
ated newly in the cDNA of W1 by means of a transformer site-directed
mutagenesis kit (Clontech). The mutagenesis primer containing the
HpaI site (underlined) was designed as 5P-CTTCCTCATCGTGGT-
TAACATGTACATTGCT, corresponding to 4734^4764 of W1 cDNA.
In this case, there is no change of the W1 amino acid sequence by
altered nucleotides. pcDNAW1-I1575A, W1-I1575K, W1-F1579A and
W1-F1579K were produced using a PCR-based mutagenesis method.
One forward primer F1 (5P-CCGCGGGGCCAAGGGCATCCG) and
four mutagenic reverse primers (I1575A, I1575K, F1579A and
F1579K) were designed for producing site-speci¢c mutants. These
mutagenic primers, with the nucleotides altered for creating a HpaI
site underlined and for producing a desired mutant set in bold, were
as follows:
I1575A: 5P-GTTAACCACGATGAGGAAGGAGATGATGGCG-
TAGCT
I1575K: 5P-GTTAACCACGATGAGGAAGGAGATGATTTTG-
TAGCT
F1579A: 5P-GTTAACCACGATGAGGGCGGAGAT
F1579K: 5P-GTTAACCACGATGAGTTTGGAGAT
These resulting PCR products correspond to nucleotides 4365^4752
of W1 cDNA, and have SacII and HpaI sites at the 5P- and the 3P-ends,
respectively. They were cloned by replacing the unique SacII-HpaI
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fragment of W1 cDNA into pcDNAW1 to produce the desired site-
speci¢c mutants. pcDNAW1-Y1586A and W1-Y1586K were also pro-
duced using a PCR-based mutagenesis method. One reverse primer
R1 (5P-GAATTCGATTCGTCTTTGTCT) and two mutagenic for-
ward primers (Y1586A and Y1586K) were designed for producing
site-speci¢c mutants. These mutagenic primers, with the nucleotides
altered for creating a HpaI site underlined and for producing a desired
mutant set in bold, were as follows:
Y1586A: 5P-GTTAACATGGCCATTGCTATC
Y1586K: 5P-GTTAACATGAAAATTGCTATC
These resulting PCR products correspond to nucleotides 4747^5827
of W1 cDNA plus GAATTC (EcoRI site), and have HpaI and EcoRI
sites at the 5P- and the 3P-ends, respectively. They were cloned by
replacing the unique HpaI-EcoRI fragment of W1 cDNA into pcDNAW1
to produce the desired site-speci¢c mutants.
On the site-speci¢c mutants of transmembrane segment D1S6,
pcDNAW1-I433A, W1-N434A and W1-L437A were produced in the
same manner as in our previous report [3]. Three mutagenic reverse
primers (I433A, N434A and L437A) were designed for producing the
desired mutants. These mutagenic primers, with the altered nucleo-
tides set in bold, were as follows:
I433A: 5P-CGTACGCCATGGCCACCACGGCCAGGATCAGA-
TTGGCGAGGT
N434A: 5P-CGTACGCCATGGCCACCACGGCCAGGATCAG-
AGCGATGAGGT
L437A: 5P-CGTACGCCATGGCCACCACGGCCGCGATCAG-
ATTGATGAGGT
All of the resulting mutants were sequenced to con¢rm the nucleo-
tide change using an ABI PRISM1 310 Genetic Analyzer (Applied
Biosystems).
2.2. Transient transfection and cell culture
The constructed plasmids described above were co-transfected with
CD8 cDNA transiently into HEK 293 using SuperFect Transfection
Reagent (Qiagen). The cells were grown to 50% con£uence in DMEM
(Gibco) containing 10% fetal bovine serum (Bio-whittaker), 30 units/
ml penicillin G (Gibco) and 30 Wg/ml streptomycin (Gibco) in a hu-
midi¢ed atmosphere of 5% CO2 and 95% air at 37‡C. The transfected
cells were used for electophysiological experiments as late as 3 to
4 days after replating in 35-mm tissue culture dishes. Transfection-
positive cells were identi¢ed by CD8-Dynabeads (Dynal) before the
Na current recording.
2.3. Electrophysiological recording
Macroscopic sodium currents from the transfected cells were meas-
ured with a patch clamp method. The bath solution contained (in
mM): 70 NaCl, 67 N-methyl-D-glucamine, 1 CaCl2, 1.5 MgCl2, 10 glu-
cose and 5 HEPES (pH 7.4). The pipette solution contained (in mM):
70 CsF, 60 CsCl, 12 NaF, 5 ethylene-bis(oxonitrilo)tetraacetic acid
and 5 HEPES (pH 7.4). To assess the e¡ects of GTX on whole-cell
sodium currents, 300 WM grayanotoxin I, a biologically active ana-
logue, was added to the pipette solutions, because GTX is known to
act intracellularly [6].
Data were presented as means þ S.D. (number of observations),
unless otherwise stated.
3. Results
3.1. Comparison of kinetic parameters of gating mechanism
among WT and mutant Na+ channels
Because a mutation introduced into Na channels may be
able to change their gating properties of Na channels, the
electrophysiological properties of WT and all mutants transi-
ently expressed in HEK 293 were analyzed by a whole-cell
voltage clamp. Typical examples of Na currents for WT
and F1579A are displayed in Fig. 1A1 and A2. Depolariza-
tion of the transfected cells gave rise to a rapidly activating
and inactivating inward current through the Na channels.
For WT and all mutants, the currents appeared at 360 mV
and reached a maximum at around 320 mV, as shown in I-V
curve in Figs. 2C and 3. The reversal potentials for peak
transient currents in W1 WT and mutants were consistent
with the value calculated by the Nernst equation. From
Fig. 1. E¡ect of the introduction of mutations into W1 on the kinetic properties of Na channels. A: Original traces of Na currents from WT
(1) and F1579A (2). Holding potential of 3120 mV. Test pulses were given in 10 mV increments from 3130 mV to 60 mV for WT and
F1579A. B: (1) The relationship between the time to peak and the membrane potentials and (2) that between df and the membrane potentials.
Symbols used are listed in inset. For the sake of clarity, error bars are listed only in WT. Statistical signi¢cance for di¡erences in the means
(P6 0.05) is expressed as an asterisk. Number of observations was six for WT and four for the rest of them.
FEBS 23142 27-12-99
T. Kimura et al./FEBS Letters 465 (2000) 18^22 19
Na current records, the time to peak was measured as rep-
resentative of the activation and the time constant for the
falling phase (df ) as that of the inactivation process. As shown
in Fig. 1B, the time to peak in most mutants is large, com-
pared with those for WT channels and df for F1579A and
Y1586K is larger than that for WT channels.
3.2. Modi¢cation of Na+ channels in WT and mutants by GTX
Including 300 WM GTX in the pipette had a marginal e¡ect
without repetitive stimulation. An impairment of fast inacti-
vation in WT induced by GTX during a single test pulse
appeared as a small persistent Na current at the end of
pulses of 12 ms (Fig. 2A). When 300 repetitive pulses to
320 mV of 6 ms in duration from a holding potential of
3120 mV were applied, GTX drastically altered the functional
properties of voltage-gated Na channels (Fig. 2B). Modi¢ca-
tion by 300 WM GTX I was manifested by a loss of peak
sodium currents and an increase in sustained currents which
started to appear at a large negative membrane potential. The
sustained currents reached a maximum at 350 mV and the
reversal potentials for slow currents shifted a little extent to
the hyperpolarizing direction, compared with that for peak
transient currents. In moderately modi¢ed mutant channels
such as Y1586A, persistent currents were accompanied by a
decrease in peak current. In the case of mutants which com-
pletely lost their sensitivities to GTX, such as F1579K and
Y1586K, the I-V curves before and after repetitive condition-
ing pulses remained unchanged in the presence of GTX.
Because the number of sodium channels expressed is di¡er-
ent from cell to cell, it is necessary for GTX-modi¢ed Na
channels to be normalized to a representative factor of normal
channel in an active state. We chose the maximum chord
conductance for sodium channel without repetitive pulses,
and measured it by adopting a straight line to data between
0 mV and 50 mV. Although GTX I was able to modify Na
channels during single depolarizing pulses to open channel,
the modi¢cation of Na channels was negligible, and was
seen as an incomplete shutdown of Na channels (Fig. 2A
as compared with Fig. 1A1). Thus, it is reasonable to employ
a family of Na currents without repetitive stimulation as a
reference. The chord conductance for GTX-modi¢ed sodium
channel was obtained by adopting a straight line to the data
for slow sustained current between 350 mV and 50 mV. The
degree of GTX-evoked modi¢cation of Na channels was
estimated as the relative chord conductance for sustained
Na currents following conditioning prepulses, in relation to
the maximum chord conductance. Results are summarized in
Table 1.
4. Discussion
Through our site-directed mutagenesis study, three items of
intriguing information were obtained: on the substitution
with alanine of the three sites in W1 homologous to those in
RBIIA which Linford et al. [4] had manipulated, ¢rst, the
mutants of I1575A and Y1586A, homologous to I1760A
Fig. 2. GTX modi¢cation in WT. Original traces of Na currents without (A) and with (B) conditioning pulses. Because GTX modi¢es Na
channels only in the open state, care was exercised to eliminate accumulated inactivation of sodium channels during repetitive conditioning
pulses. Recovery from inactivation was measured using a two-pulse protocol, with conditioning and test pulses separated by a variable time in-
terval. The time course of recovery from inactivation could be described as a single exponential, giving the time constant of 1.1 þ 0.3 ms (n = 3)
for WT, 3.8 þ 1.1 ms (n = 3) for I1575A, 1.6 þ 0.3 ms (n = 4) for F1579A, 1.6 þ 0.2 ms (n = 3) for Y1586A, 1.9 þ 0.5 ms (n = 5) for 1579K and
114.9 þ 21.8 ms (n = 4) for Y1586K. As time constants for all mutants except Y1586K were similar, we set the time interval of 20 ms during re-
petitive pulsing. Because the recovery from inactivation in F1586K was unusually slow, giving a time constant of 114.9 ms, to induce GTX
modi¢cation the time interval during repetitive conditioning pulses was set to be 500 ms in this particular mutant. Depolarizing pulses were
triggered every 10 s. In A and B, holding potential of 3120 mV. Test pulses were given in 10 mV increments from 3130 mV to 50 mV. In C,
amplitudes of transient current (closed circles) and of sustained current measured at the end of 160 ms test pulse (open circles) in 10 mV incre-
ments from 3140 mV to 50 mV are plotted against membrane potentials.
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and Y1771A in RBIIA, resulted in a mutant with a totally lost
and with a substantially reduced sensitivity to GTX I, respec-
tively, second, the mutant of F1579A, homologous to F1764A
in RBIIA, was found to increase the GTX-e¡ect signi¢cantly,
and third, on the replacement of these sites by lysine, W1-
Y1586K became totally resistant to GTX I and GTX I was
a less e¡ective modi¢er of mutant W1-F1579K than of WT
channels. These observations imply that these three sites are
involved in GTX binding. The loss and extensive reduction
respectively of sensitivity to GTX on the introduction of ala-
nine into I1575 and Y1586 indicate that these sites may be
directly bound by GTX. Meanwhile, the enhancement of the
GTX-e¡ect seen in F1579A may well suggest the easy access
of GTX to the binding site due to the reduction of steric
hindrance by the side chain. McPhee et al. [7] reported that
in mutant F1764A in RBIIA, homologous to mutant F1579A,
the stability of the inactivated state is impaired, because sub-
stantial sustained Na currents at the end of 30 ms depolari-
zation were observed. As shown in Fig. 1, the kinetic param-
eters for both activation and inactivation in this mutant also
belong to the most sluggish group. An alternative explanation
for the augmented modi¢cation in F1579A is that the Na
channels, having an unstable inactivation state, might be
transferred more easily to those in a GTX-modi¢ed state.
Because the structure-activity relation for GTX binding re-
vealed that GTX requires a condition favorable for hydro-
phobic and hydrogen bonding for exerting pharmacological
action [8^10], introduction of hydrophilic lysine into the sites
critical for GTX binding is thought to disturb the hydropho-
bic microenvironment around these sites and lead to loss of
the GTX-e¡ect. A typical example is that, by changing the
substituent from A to K in F1579, the relative conductance
for F1579A of twice bigger than that for WT decreased to a
marginal value. A similar trend, though to a lesser extent, was
also recognized in the case of Y1586 (see Table 1). Taken
altogether, point mutation experiments using two di¡erent
substituents with distinctive chemical properties gave a con-
sonant conclusion for GTX binding sites in D4S6.
Linford et al. [4] showed that, when amino acids falling on
the same face of the predicted D4S6 K-helix, I1760, F1764 and
Y1771 in RBIIA, were substituted by alanine, the BTX-e¡ects
were eliminated completely for the F1764A mutant, were re-
duced substantially for mutant I1760A, but remained un-
changed in Y1771A. From these observations they suggested
that the BTX receptor sites are localized in I1760 and F1764
in transmembrane segment D4S6. Wang and Wang [2] sug-
gested that D4S6 has a possible involvement in BTX binding,
using the lysine substitution method. Our results agree with
Fig. 3. I-V curves for peak current without conditioning pulses (closed circles) and steady currents with conditioning pulses (open circles) in
various mutants. The pulse protocol for these records was the same as that given in Fig. 2. The mutants tested are speci¢ed in each graph ab-
breviated form. The inset ¢gure shows the amino acid sequences for D4S6 of RBIIA and W1 (the numbers represent amino acid sequence num-
bering from the beginning). Asterisks (*) for rBIIA and for W1 indicate the sites of action for BTX claimed by Linford et al. [4] and by Wang
and Wang [2], respectively. Diamonds (8) for W1 indicate the site for GTX.
Table 1
Relative chord conductance in W1 and its mutants
W1 I1575A F1579A Y1586A
mean þ S.D. (number) 0.35 þ 0.04 (n = 9) 0.00 (n = 3) 0.75 þ 0.16 (n = 5) 0.06 þ 0.16 (n = 3)
I1575K F1579K Y1586K
mean þ S.D. (number) not expressed 0.04 þ 0.01 (n = 3) 0.00 (n = 3)
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the general scheme presented by Linford et al. [4], though with
some minor di¡erences in the crucial sites for BTX from those
for GTX.
As for alanine substitution at the sites in which we have an
interest, Wang and Wang [2] reported that F1579A and
Y1586A in W1 are BTX-sensitive. We independently clari¢ed
that W1-I1575A, a mutant so far unexplored, is also as sensi-
tive to 10 WM BTX as WT (data not shown). This ¢nding
indicates that the introduction of alanine into these sites in W1
does not a¡ect the BTX-e¡ect. However, the substitution of
lysine for F1579 eliminated the BTX-e¡ect, but substitution of
the same amino acid for Y1586 did not. The disparity of the
conclusion on the role of F1579 in BTX binding in W1 be-
tween the alanine and lysine substitution methods is problem-
atic. A possible explanation is that BTX molecules fail to get
access to the binding sites, which are located elsewhere, be-
cause of perturbation of the microenvironment around nearby
binding sites. To con¢rm this supposition, we extended our
study on the e¡ect of GTX I to three mutants made by ala-
nine substitution, I433, N434 and L437, which were thought
to be the binding sites using lysine substitution [3]. The rela-
tive conductance was estimated to be 0.09 þ 0.02 (n = 4) for
I433A, 0 (n = 2) for N434A and 0.33 þ 0.10 (n = 4) for
L437A. An extensive reduction of sensitivity was recognized
in I433A and N434A in accordance with the results previously
obtained [3], but the relative conductance for L437 was as
large (0.35) as for WT. As mentioned earlier, a similar change
was recognized on switching the substituent from A to K in
F1579 (see Table 1). As far as D1S6 and D4S6 are concerned,
the possible binding sites of I433 and N434 in D1S6 and
I1575A in D4S6 are aligned right next to the sites of L437
and F1579 under discussion, if the secondary structure of
these segments is K-helical. Because the introduction of lysine
into L437 and F1579 changes the local environment exten-
sively, hydrophilic moiety lysine may well cover the binding
sites and GTX fails to gain access. Although W1-N1584 was
claimed to be a site of action of BTX [2], the same rationale
may account for the apparent unlikelihood of this claim, since
it was also recognized that alanine substitution does not in-
duce a complete BTX-resistant channel.
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